Evidence map›Paper›PMID 1922024›Full record

ArticleMolecular and cellular biology1991

Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation.

C L Miller, A L Feldhaus, J W Rooney, L D Rhodes, C H Sibley, H Singh

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Architectural DNA binding by a high-mobility-group/kinesin-like subunit in mammalian SWI/SNF-related complexes.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration.Proceedings of the National Academy of Sciences of the United States of America · 1994
    Article
  12. Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation.Proceedings of the National Academy of Sciences of the United States of America · 1994
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

C L MillerDepartment of Molecular Genetics and Cell Biology, University of Chicago, Illinois 60637.
A L Feldhaus
J W Rooney
L D Rhodes
C H Sibley
H Singh
University of Chicago · US

Funding

Molecular And Cellular Biology Training ProgramT32GM007183 · NIGMS · UNIVERSITY OF CHICAGO · PI GLICK, BENJAMIN S, RICE, PHOEBE A · 1985 to 2021
$23.9M
TRAINING IN MOLECULAR AND CELLULAR BIOLOGYT32GM007270 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAIBLE, DAVID W · 1985 to 2020
$21.0M
ROLE OF SYK KINASE AND CD22 IN B CELL ACTIVATIONP01GM042508 · NIGMS · UNIVERSITY OF WASHINGTON · PI SIBLEY, CAROL HOPKINS · 1989 to 1997
–
NIGMS NIH HHS GM07183NIGMS NIH HHS GM07270NIGMS NIH HHS GM42508
6 · The paper itself

Abstract

The Oct-2 gene appears to encode a developmental regulator of immunoglobulin gene transcription. We demonstrate that the Oct-2 gene is expressed at low levels in a variety of transformed pre-B-cell lines and is induced specifically in these cells by lipopolysaccharide signalling. This work extends an earlier observation in the pre-B-cell line 70Z/3 and therefore suggests that the inducible expression of the Oct-2 gene, like that of the kappa gene, is a characteristic feature of the pre-B stage of B-cell development. In 70Z/3 cells, the lymphokine interleukin-1 also induces the expression of the Oct-2 and kappa loci. Interestingly, expression of the Oct-2 gene is rapidly induced at the transcriptional level and may not require de novo protein synthesis. Since the changes in the activity of the Oct-2 locus completely correlate with the changes of the activity of the kappa locus, the two genes may be transcriptionally regulated by a common trans-acting factor. In 70Z/3 cells, transforming growth factor beta, an inhibitor of kappa-gene induction, blocks the upregulation of Oct-2 but not the activation of NF-kappa B. These results suggest that the combinatorial action of increased levels of Oct-2 and activated NF-kappa B may be necessary for the proper stage-specific expression of the kappa locus.

Indexed as

DNA-Binding ProteinsAnimalsBlotting, NorthernBlotting, WesternB-LymphocytesCell DifferentiationCell LineCells, CulturedGene Expression RegulationImmunoglobulin kappa-ChainsInterleukin-1LipopolysaccharidesMiceOctamer Transcription Factor-2Transcriptional ActivationTranscription FactorsDNA-Binding ProteinsImmunoglobulin kappa-ChainsInterleukin-1LipopolysaccharidesOctamer Transcription Factor-2Pou2f2 protein, mouseTranscription FactorsTransforming Growth Factor beta

Identifiers

PMID1922024
PMCPMC361457
OpenAlexW1828083087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.